- Home
- AVD vs TVGN Comparison
AVD vs TVGN Comparison
Compare AVD & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- TVGN
- Stock Information
- Founded
- AVD 1969
- TVGN 2020
- Country
- AVD United States
- TVGN United States
- Employees
- AVD N/A
- TVGN N/A
- Industry
- AVD Agricultural Chemicals
- TVGN Blank Checks
- Sector
- AVD Industrials
- TVGN Finance
- Exchange
- AVD Nasdaq
- TVGN Nasdaq
- Market Cap
- AVD 153.8M
- TVGN 184.5M
- IPO Year
- AVD N/A
- TVGN N/A
- Fundamental
- Price
- AVD $5.43
- TVGN $0.94
- Analyst Decision
- AVD Strong Buy
- TVGN Strong Buy
- Analyst Count
- AVD 1
- TVGN 1
- Target Price
- AVD $12.00
- TVGN $10.00
- AVG Volume (30 Days)
- AVD 297.0K
- TVGN 1.5M
- Earning Date
- AVD 07-31-2025
- TVGN 08-14-2025
- Dividend Yield
- AVD N/A
- TVGN N/A
- EPS Growth
- AVD N/A
- TVGN N/A
- EPS
- AVD N/A
- TVGN N/A
- Revenue
- AVD $529,067,000.00
- TVGN N/A
- Revenue This Year
- AVD N/A
- TVGN N/A
- Revenue Next Year
- AVD $3.54
- TVGN N/A
- P/E Ratio
- AVD N/A
- TVGN N/A
- Revenue Growth
- AVD N/A
- TVGN N/A
- 52 Week Low
- AVD $3.28
- TVGN $0.26
- 52 Week High
- AVD $6.68
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- AVD 68.86
- TVGN 41.12
- Support Level
- AVD $5.00
- TVGN $0.89
- Resistance Level
- AVD $5.35
- TVGN $1.10
- Average True Range (ATR)
- AVD 0.27
- TVGN 0.10
- MACD
- AVD 0.05
- TVGN 0.00
- Stochastic Oscillator
- AVD 97.30
- TVGN 18.67
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.